Dietary K<sup>+</sup> supplementation restores normal aldosterone level in Na<sup>+</sup>-deprived renal tubule-specific CAP1/Prss8-deficient mice
We previously reported that Na<sup>+</sup>-deprived mice lacking CAP1/Prss8 in kidney tubules maintained epithelial sodium channel-mediated sodium balance albeit persistent hypoaldosteronism, hence indicating an uncoupling from aldosterone production. This further suggested an implication of the serine protease CAP1/Prss8 (prostasin) in the cross talk of the kidney with the adrenal gland that does not express prostasin. When these knockout (Ko) mice were additionally exposed to a high K<sup>+</sup> diet, plasma K<sup>+</sup> levels and plasma aldosterone concentrations were normalized and no longer different from those of the control mice. The mRNA transcript expression of the adrenal aldosterone synthase <i>Cyp11b2,</i> which was lower in Na<sup>+</sup>-deprived <i>CAP1/Prss8</i> Ko animals, was in the normal range. Plasma aldosterone levels were similar to control animals, indicating that K<sup>+</sup> rescued the hypoaldosteronism in Na<sup>+</sup>-deprived <i>CAP1/Prss8</i> Ko animals. These data suggest that CAP1/Prss8 (prostasin) is implicated in the regulation of aldosterone synthesis or production and that the consequences of <i>CAP1/Prss8</i> deficiency can be compensated by high dietary K<sup>+</sup> supplementation. Prostasin may therefore present a promising regulator of aldosterone production by affecting the adrenal steroidogenic pathway.<b>NEW & NOTEWORTHY</b> We explore the role of the serine protease CAP1/Prss8 in aldosterone synthesis. Described previously as a candidate gene for hypertension, the mechanism by which renal serine protease deficiency is implicated in aldosterone production is still largely unknown. Our findings underscore a role of prostasin in the regulation of aldosterone synthesis. In kidney-specific <i>CAP1/Prss8</i> knockout mice, K<sup>+</sup> supplementation is predominant over Na<sup>+</sup> and restores normal aldosterone production proposing new pathways to treat hypo- or hypertension.
Authors
- Elodie Ehret (ORCID: https://orcid.org/0000-0003-0181-4893)
- Muriel Auberson (ORCID: https://orcid.org/0009-0007-4308-8750)
- Olivier Staub (ORCID: https://orcid.org/0000-0002-1799-9784)
- Edith Hümmler (ORCID: https://orcid.org/0000-0002-3887-2715)
- Dongmei Wang (ORCID: https://orcid.org/0000-0001-9532-6203)
Institutions
- University of Lausanne (CH)
Publication Details
- Journal
- American Journal of Physiology-Renal Physiology
- Published
- 2025-09-12
- DOI
- https://doi.org/10.1152/ajprenal.00224.2025
- Primary Topic
- Hormonal Regulation and Hypertension
- Type
- article
- Field-Weighted Citation Impact
- 0.00